aurora is a canadian company and licensed producer of artisanal medical marijuana pursuant to the marihuana for medical purposes regulations. we ensure the highest quality, reliability, and safety of our products through advanced cultivation techniques carried out in our 55,200 square foot expandable state-of-the-art production facility in alberta, canada. aurora’s wholly-owned subsidiary, australis capital inc., seeks to be an active participant in the u.s. cannabis market.
Company profile
Ticker
ACB
Exchange
Website
CEO
Michael Singer
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
ACB stock data
Latest filings (excl ownership)
6-K
Current report (foreign)
1 Mar 24
6-K
Aurora Cannabis Announces CFO Transition and Completion of Previously Announced Share Consolidation
20 Feb 24
6-K
Material Change Report
16 Feb 24
6-K
Aurora Cannabis Announces Fiscal 2024 Third Quarter Results; Generates Record Adjusted EBITDA of $4.3 Million
8 Feb 24
6-K
Condensed Consolidated Interim Financial Statements
8 Feb 24
6-K
Aurora Cannabis Acquires MedReleaf Australia
8 Feb 24
6-K
Aurora Cannabis Provides Business Update and Announces Date of Third Quarter Fiscal Year 2024 Investor Conference Call
31 Jan 24
6-K
Aurora Cannabis Announces Fiscal 2024 Second Quarter Results and Delivers Record Positive Adjusted EBITDA
9 Nov 23
6-K
Condensed Consolidated Interim Financial Statements
9 Nov 23
6-K
Aurora Cannabis to Host Second Quarter Fiscal Year 2024 Investor Conference Call
27 Oct 23
Transcripts
ACB
Earnings call transcript
2023 Q1
11 Nov 22
ACB
Earnings call transcript
2022 Q4
21 Sep 22
ACB
Earnings call transcript
2022 Q3
13 May 22
ACB
Earnings call transcript
2022 Q2
11 Feb 22
ACB
Earnings call transcript
2021 Q1
10 Nov 21
ACB
Earnings call transcript
2021 Q4
28 Sep 21
ACB
Earnings call transcript
2021 Q3
14 May 21
ACB
Earnings call transcript
2021 Q2
12 Feb 21
ACB
Earnings call transcript
2021 Q1
9 Nov 20
Financial summary
Quarter (USD) | Mar 23 | Jun 22 | Jun 21 | Jun 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Mar 23 | Jun 22 | Jun 21 | Jun 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q3 2023
84.7% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 211 |
Opened positions | 37 |
Closed positions | 25 |
Increased positions | 43 |
Reduced positions | 33 |
13F shares | Current |
---|---|
Total value | 16.83 bn |
Total shares | 46.21 mm |
Total puts | 942.80 k |
Total calls | 4.20 mm |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
CVI Investments | 15.78 mm | $0.00 |
MMCAP International Inc. SPC | 8.00 mm | $4.66 bn |
Renaissance Technologies | 6.36 mm | $3.71 bn |
Mirae Asset Global Investments | 2.89 mm | $1.69 bn |
Susquehanna International | 1.63 mm | $952.20 mm |
Millennium Management | 1.63 mm | $949.84 mm |
Yong Rong | 1.50 mm | $878.00 k |
MS Morgan Stanley | 1.14 mm | $669.52 mm |
AXS Investments | 1.13 mm | $659.51 mm |
Dimensional Fund Advisors | 862.92 k | $504.81 mm |
News
Bearish Sentiment Across The Cannabis Space - Check Full Movers For April 18, 2024
18 Apr 24
Marijuana Stock Movers For April 17, 2024
17 Apr 24
'Senator Presses Attorney General Garland On Marijuana Banking Bill's Impact On Criminal Investigations' - Marijuana Moment
17 Apr 24
Another Cannabis Pioneer Expands In Germany Via Acquisition As Experts Say 'There's No Stepping Back' From Legalization Wave
17 Apr 24
Cannabis Stock Gainers And Losers From April 16, 2024
16 Apr 24
Press releases
International Star Inc. Appoints Todd Masse as New CEO
10 Apr 24
Sector Spotlight: Top 4 Stocks To Watch In The Rising Cannabis Market
8 Apr 24
Aurora Cannabis Commends Germany's Landmark Legalization Achievement
1 Apr 24
Aurora Cannabis Achieves Australia's TGA GMP Certification, Setting Global Standard for Quality and Compliance
20 Mar 24
Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia
4 Mar 24